Clinical results for advair diskus 1 significantly fewer patients receiving advair diskus 250 50 fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder were withdrawn from a 12 week study for worsening asthma compared with fluticasone propionate salmeterol and placebo. Advair diskus 250 50 is a twice daily prescription medicine used long term to treat chronic obstructive pulmonary disease copd including chronic bronchitis emphysema or both for better breathing and fewer flare ups. Fluticasone salmeterol is an inhaled drug used to treat asthma and chronic obstructive pulmonary disease copd learn about side effects warnings dosage and more. Advair diskus is a combined preparation which contains salmeterol and fluticasone propionate which have different mechanisms of action salmeterol prevents bronchospasm symptoms fluticasone propionate improves respiratory function and prevents exacerbations. Advair comes as a dry powder inhaler advair diskus and metered dose inhaler advair hfa 12 advair diskus is approved for the treatment of asthma for people ages four years and up as well as copd chronic obstructive pulmonary disease advair hfa is only approved for asthma for people ages 12 years and up
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )